Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DZ7Q8I
|
|||
| Drug Name |
RG6299
|
|||
| Drug Type |
Antisense oligonucleotide
|
|||
| Indication | Geographic atrophy [ICD-11: 9B75] | Phase 2 | [1] | |
| IgA nephropathy [ICD-11: MF8Y] | Phase 2 | [1] | ||
| Company |
Ionis
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Complement factor B (CFB) | Target Info | . | [1] |
| KEGG Pathway | Complement and coagulation cascades | |||
| Staphylococcus aureus infection | ||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| Reactome | Alternative complement activation | |||
| Activation of C3 and C5 | ||||
| Regulation of Complement cascade | ||||
| WikiPathways | Complement and Coagulation Cascades | |||
| Human Complement System | ||||
| Complement cascade | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Roche | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.